⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CGEN News
Compugen Ltd
Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026
prnewswire.com
CGEN
Compugen Reports First Quarter 2026 Results
prnewswire.com
CGEN
Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum
prnewswire.com
CGEN
Accretropin (Cangene) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
CGEN
Compugen Reports Fourth Quarter and Full Year 2025 Results
prnewswire.com
CGEN
Advanced Serial Plasma Exchange Arrives in Beverly Hills as Los Angeles Faces Rising Environmental Health Concerns
prnewswire.com
CGEN
Compugen to Participate in Upcoming Investor Conferences
prnewswire.com
CGEN
Compugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of Directors
prnewswire.com
CGEN
TIGIT Inhibitors Market Poised for Strong Growth Through 2034, Driven by Expanding Immuno-Oncology Pipeline | DelveInsight
prnewswire.com
RCUS
GILD
AZN
CGEN
CHRS
TIGIT Inhibitors Drugs Clinical Trials & Global Market Opportunity Outlook 2026-2030 with Focus on US, China, South Korea, Australia, and Europe - ResearchAndMarkets.com
businesswire.com
GILD
MRK
CGEN
VIR